In prostate cancer, BMP6 signaling appears to promote cancer progression (Darby et al., 2008; Lu et al., 2017), while BMP7 induces quiescence in metastatic cancer cells (Kobayashi et al., 2011). Here, BMP6 is linked to cancer.